Ripple kopen? Dit zijn de mogelijkheden

Regeneron Pharmaceuticals Aandeel

298,11USD -4,98USD -1,64%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Regeneron Pharmaceuticals Inc. - Profiel

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Aandeelhouder

Eigenaar in %
Freefloat75,72
Sanofi21,91
Capital Research & Management Co. (World Investors)6,95
The Vanguard Group, Inc.5,49
BlackRock Fund Advisors4,01
Fidelity Management & Research Co.3,94
SSgA Funds Management, Inc.3,22
Loomis, Sayles & Co. LP2,95
Harris Associates LP2,48
Wellington Management Co. LLP1,97
Sands Capital Management LLC1,85
T. Rowe Price Associates, Inc. (Investment Management)1,63
Polen Capital Management LLC1,49
Capital Research & Management Co. (International Investors)1,47
Invesco Capital Management LLC1,12

Adres

777 Old Saw Mill River Road, 10591-6707 Tarrytown
Postbus:
Telefoon: 19148477000
Fax:
Internet: http://www.regeneron.com

Management

P. Roy Vagelos, MD
Chairman
Beth F. Levine
Chief Compliance Officer & Senior Vice President
Robert E. Landry
Chief Financial Officer & Executive VP-Finance
Leonard S. Schleifer MD, PhD
Co-President, Chief Executive Officer & Director
George Damis Yancopoulos MD, PhD
Co-President, Director & Chief Scientific Officer
Neil Stahl, PhD
Executive VP-Research & Development
Joseph L. Goldstein, MD
Independent Director
Christine A. Poon, MBA
Independent Director
George L. Sing, MBA
Independent Director
Michael S. Brown, MD
Independent Director
Arthur Frederick Ryan
Independent Director
N. Anthony Coles Jr., MD
Independent Director
Marc Tessier-Lavigne, PhD
Independent Director
Huda Y. Zoghbi, MD
Independent Director
Bonnie L. Bassler, PhD
Independent Director
Mark Hudson
Investor Relations Contact
Joseph Ricculli
Media Relations Contact
Daniel P. Van Plew, MBA
SVP, GM-Industrial Operations & Product Supply
Joseph J. LaRosa
Secretary, Executive VP & General Counsel
Hala Mirza
Senior VP-Corporate Communications & Citizenship
Marion McCourt
Senior Vice President & Head-Commercial
Peter Powchik, MD
Senior Vice President-Clinical Development
Sally A. Paull
Senior Vice President-Human Resources
Jay S. Markowitz, PhD
Senior Vice President-Portfolio Management
Ned Braunstein, MD
Senior Vice President-Regulatory Affairs
Christopher Fenimore, CPA
Vice President & Controller
Alan Shuldiner, MD
Vice President-Translational Genetics

Invoer toevoegen